Phase
Condition
Renal Cancer
Cancer
Urothelial Cancer
Treatment
MR-guided Linac
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants must have a confirmed malignancy requiring stereotactic body radiationtherapy. See specific disease site cohorts for more details.
Tumor size ≤ 7cm
Age 18 years of older.
ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)
Ability to understand and the willingness to sign a written informed consentdocument.
Specific eligibility requirements for each disease site with be covered in eachspecific cohort.
Exclusion
Exclusion Criteria:
Specific exclusion requirements for each disease site with be covered in eachspecific cohort
History of allergic reactions attributed to gadolinium-based IV contrast.
-- Note: If a patient will not receive contrast, this is not applicable
Pregnant women are excluded from this study.
Severe claustrophobia or anxiety
Participants who cannot undergo an MRI
Study Design
Study Description
Connect with a study center
Brigham & Women's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts 02115
United StatesSite Not Available
Brigham & Women's Hospital
Boston 4930956, Massachusetts 6254926 02115
United StatesActive - Recruiting
Dana Farber Cancer Institute
Boston 4930956, Massachusetts 6254926 02115
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.